Application of medication therapy management-based “in-hospital assessment - home-based intervention” pharmaceutical care in patients with depression

Table 6 Longitudinal comparison of quality-of-life scores between two groups of patients with depression

Indicator	Time point	Intervention group (n = 52)	Control group (n = 52)	t value	P value
SF-36 Physical Health score	Baseline	45.32 ± 8.25	44.87 ± 7.93	0.294	0.769
	3 months	52.45 ± 8.62	46.32 ± 8.15	3.625	< 0.001
	6 months	62.14 ± 9.37	52.45 ± 8.62	5.321	< 0.001
	9 months	68.75 ± 10.21	54.38 ± 9.15	7.248	< 0.001
SF-36 Mental Health score	Baseline	38.24 ± 7.63	37.85 ± 7.28	0.258	0.797
	3 months	52.45 ± 8.34	42.38 ± 7.95	6.246	< 0.001
	6 months	65.83 ± 8.92	49.76 ± 8.34	9.263	< 0.001
	9 months	72.41 ± 9.56	51.62 ± 8.73	11.037	< 0.001
WHOQOL-BREF Social Function score	Baseline	42.56 ± 6.87	41.93 ± 6.54	0.432	0.666
	3 months	48.67 ± 7.83	43.25 ± 7.15	3.625	< 0.001
	6 months	60.34 ± 8.25	48.67 ± 7.83	6.735	< 0.001
	9 months	66.89 ± 9.12	50.24 ± 8.45	8.924	< 0.001

Data are presented as mean ± SD. SF-36: 36-Item Short Form Health Survey; WHOQOL-BREF: World Health Organization Quality of Life-BREF.